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ABSTRACT
Pheochromocytoma is a rare neuroendocrine tumor diag-
nosed in 1:50 000 pregnancies. Normal physiologic changes
associated with pregnancy often make early recognition
difficult and diagnosis delayed. Treatment consists of
medical followed by surgical intervention. This case of a
34-year-old African American female diagnosed with an
adrenal pheochromocytoma during her second trimester
of pregnancy is the first reported case of successful robotic
resection. The robot provided advantages, such as en-
hanced visualization and freedom of dissection, within
this confined space. These added benefits over traditional
laparoscopy provide a means for performing difficult pro-
cedures within a decreased space possibly allowing for
interventions in later or larger pregnancies.
Key Words: Pheochromocytoma, Pregnancy, da Vinci
robot.
INTRODUCTION
Pheochromocytoma is a rare tumor. When present, defin-
itive treatment depends on surgical resection after ade-
quate preoperative blood pressure control. Diagnosis dur-
ing pregnancy poses unique issues in both timing and
method of removal. Ideal timing for surgery is during the
second trimester. At this point, organogenesis is complete,
risk of miscarriage is low, and the uterus is still small
enough to permit adequate visualization.1 Laparoscopic
removal is the most common method of resection, with
robotic surgery reports emerging in the literature.2-4 Ro-
botic surgery has been applied to gynecology proving to
be a feasible and successful preferred alternative to lapa-
roscopy for complex operations.5 We present the first case
of robotic resection of pheochromocytoma during the
second trimester of pregnancy. The robot offers unique
advantages over laparoscopy in this situation. In this al-
ready complex case, the robot provides better visualiza-
tion and facilitates easier dissection in a smaller operative
space.
CASE REPORT
A 34-year-old African American female (G1P0) with a
history of appendectomy at 10 years of age and uncon-
trolled hypertension presented to an outpatient clinic
complaining of headache and palpitations. One year ear-
lier, she presented to a primary care physician with head-
aches and hypertension. At that time, she underwent an
abdominal computed tomography (CT) which revealed a
right adrenal mass. She was started on labetalol and hy-
drochlorothiazide and refused further evaluation or fol-
low-up. On presentation to the clinic, she had not been
taking any medications and was hypertensive (170-180/
110-120). Unbeknownst to the patient, she was also found
to be pregnant, at approximately 21 weeks gestation. An
ultrasound was done at the clinic which revealed a normal
fetal evaluation and a right adrenal mass approximately 5
cm in diameter. With a high suspicion of a catecholamine-
producing tumor, blood screening and 24-urine collection
was performed. The diagnosis of a pheochromocytoma
was confirmed by concentrations of norepinephrine mea-
suring 6109 pg/mL (reference range, 112 to 658) present
in the blood with normal values of epinephrine and do-
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CASE REPORTpamine. The urine normetanephrine level was 8776 mcg/
24h (reference range, 35 to 482). An MRI was also per-
formed showing increased signal, T2 weighed, with a
right adrenal tumor measuring5x4x3 . 7c m(Figure 1).
No additional tumors were visualized.
The patient was transferred to a high-risk pregnancy
clinic. Phenoxybenzamine, the nonselective  (alpha)
blocker, 20 mg 4 times a day was started. Labetalol 100mg
3 times a day was added as well. After 10 days of moni-
toring in the hospital, the patient was taken to the oper-
ating room. Normotensive blood pressure goals (120-130/
70-80 mm Hg) were achieved after medication with an
average blood pressure of 125-130/75-80 mm Hg preop-
eratively.
Surgical Technique
A robotic-assisted laparoscopic adrenalectomy was per-
formed via transperitoneal endoscopic access with the
patient under general anesthesia. The patient was placed
in the left lateral decubitus position with the da Vinci
Robotic System to her right. (Intuitive Surgical, Inc.) Five
trocars were placed. A 12-mm trocar was placed 7 cm
below the subcostal margin with anterior axillary line
under direct visualization. Through this port, pneumoperi-
toneum was created. The abdominal cavity was inspected
with no evidence of additional masses. The 21-week
gravid uterus was visualized with no sign of abnormality
(Figure 2). A 5-mm trocar was then placed in the subxi-
phoid region for retraction of the left lateral segment of
the liver. Two 8-mm trocars were placed, one 7 cm below
the subcostal margin in the midaxillary line and the sec-
ond 4cm below the subcostal margin in the midclavicular
line. Finally, a 5-mm assistant trocar was placed in the left
upper quadrant. The da Vinci Robotic System was then
attached to the trocars.
The left lateral segment of the liver was retracted allowing
division of the triangular ligament to facilitate tumor ex-
posure. The retroperitoneum was dissected along the in-
ferior edge of the liver until the mass was visible. The
duodenum was then mobilized, exposing the mass and
inferior vena cava (IVC) (Figure 3).
The adrenal vein was identified by dissecting along the
medial aspect of the mass taking down small tributaries of
the IVC with a combination of the Harmonic scalpel and
suture ligation (Figure 4). Next, careful medial to lateral
dissection of the tumor from the IVC and mobilization off
the inferior pole of the kidney was performed. Finally, the
upper pole of the mass occupying the retrohepatic space
was dissected. During this dissection, an abnormal ana-
tomical variation of the adrenal vein was found. A vascular
Figure 1. Right adrenal tumor magnetic resonance.
Figure 2. Uterus.
Figure 3. Medial dissection of mass from inferior vena cava.
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zation (Figure 5). The tumor was extracted through the
12-mm trocar.
RESULTS
During the procedure, blood pressure was controlled with
consistent values between 120-130/80 mm Hg and a heart
rate of 85 to 95 beats per minute. Operative time was 270
minutes. The estimated blood loss was 350 mL. Blood
gases were monitored via arterial line, ensuring accept-
able carbon dioxide levels. The patient was extubated
upon completion of the surgery without difficulty. Patho-
logic examination reported histological features compati-
ble with benign pheochromocytoma of 5.3 x 4.2 x 3.7 cm
(Figure 6).
The postoperative course was uneventful. The patient was
ambulatory on the night of surgery reporting minimal
pain. Her diet was advanced beginning postoperative day
number one. A fetal ultrasound was performed reassuring
the presence of a healthy fetus. The patient was dis-
charged on postoperative day 4. Postoperative follow-up
at days 5, 30, and 60 were uneventful. Her blood pressure
and heart rate were within normal limits, and the patient
remained symptom free.
The patient was followed at the outpatient obstetrics clinic
after discharge. All fetal ultrasounds were normal along
with normal blood pressure readings. Induction at 39
weeks for oligohydramnios failed and a cesarean delivery
was performed. A healthy baby boy was delivered without
complication. One month postpartum, the patient’s blood
pressure remained stable without medication.
DISCUSSION
Pheochromocytoma is a rare neuroendocrine tumor, af-
fecting 0.2% of hypertensive individuals. These tumors
most commonly arise from neuroectodermal chromaffin
cells in the adrenal glands. Production of catecholamines
and vasoactive peptides results in hypertension, head-
aches, and palpitations. Diagnosis is confirmed by ele-
vated plasma and urine catecholamine levels along with
radiologic tumor identification by CT or MRI. Although
definitive treatment is surgical, blood pressure control
with alpha- followed by beta-blockade must be achieved
preoperatively.
Rarely, this uncommon tumor presents in pregnancy,
Figure 4. Suture ligation of right adrenal vein.
Figure 5. Dissected mass.
Figure 6. Dissected mass.
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pheochromocytoma occurs only once in 50 000 preg-
nancies, it carries a high risk of fetal and maternal mor-
bidity and mortality. Early recognition is crucial but often
difficult, because presenting symptoms may vary from
minor hypertension to cardiovascular collapse. Delayed
diagnosis significantly increases undesired outcomes. For-
tunately, increased suspicion, utility of screening labora-
tory tests, and prompt initiation of treatment has de-
creased maternal mortality from 46% to 4% and fetal
mortality from 55% to 15% over the last 15 years.6
Biochemical diagnosis is the same as in nonpregnant
patients. MRI is the preferred modality of choice for tumor
localization, avoiding ionizing radiation to the fetus. Initial
treatment is to control the blood pressure, first with alpha-
blockers, such as phenoxybenzamine. Preoperative beta-
blockade preferably with a selective beta-1 antagonist is
initiated several days before surgery.
Timing of surgical resection is controversial. Maternal mor-
bidity increases with progression of the pregnancy as uterine
position and/or contraction, or fetal movement results in
abrupt catecholamine release provoking lethal conse-
quences, such as myocardial infarction or cerebral hemor-
rhage. The placenta metabolizes maternal catecholamines,
protecting the fetus. Fetal demise results from uncontrolled
hypertension, not directly from catecholamine surges.7 If
diagnosed early in the first trimester, termination should
be offered. Late first trimester or early second trimester
resection may be ideal. Diagnosis in the late second tri-
mester or third trimester may require delay in resection
until fetal lung maturity is attained, often combining ce-
sarean delivery and resection.
Pregnancy was previously a contraindication to laparos-
copy. The already present physiologic changes were
thought to be increased by the pneumoperitoneum. In-
creased abdominal tension could compress the vena cava
further reducing flow. Additionally, there was concern
regarding the effect of the carbon dioxide on the devel-
oping fetus. Safe entry into the abdominal cavity was also
a concern due to the displacement of anatomy by the
gravid uterus.
Fortunately, it was realized that the known advantages of
laparoscopic surgery may be expanded to this high-risk
population.8 Faster recovery results in earlier ambulation,
decreasing the risk of thromboembolism in this hyperco-
agulable group of patients. Return of gastrointestinal func-
tion is also more rapid than with an open procedure.
Decreased narcotic requirements limit potentially damag-
ing effects on the developing fetus. Small incisions de-
crease the potential for herniation with the increased pres-
sure of the uterus. Laparoscopy also offers enhanced
visualization without manipulating the uterus, resulting in
decreased incidence of preterm labor.
Case reports and series of laparoscopic appendectomy
and cholecystectomy proved the minimally invasive ap-
proach to be a viable alternative during pregnancy.9,10
From the collective reviews of these reports, SAGES pub-
lished guidelines for laparoscopy in pregnancy. The first
trimester should be avoided as organogenesis is incom-
plete and miscarriage is likely. The third trimester is often
too late for intervention. By this point, the gravid uterus
precludes adequate visualization. Attempts of insufflation
may stimulate premature contractions resulting in prema-
ture labor before fetal lung maturity is complete. The
second trimester is recommended as the ideal time for
surgical intervention.1,11 Spontaneous miscarriage rates
decrease from approximately 15% in the first trimester to
approximately 0% in the second trimester with a 5% risk of
preterm labor.12 Medical therapy should be initiated at
least 10 days before surgery to obtain normal blood pres-
sure values and adequate volume reconstitution.12 The
optimal surgical candidate should have a supine arterial
pressure 160/90 mm Hg, orthostatic hypotension not
exceeding 80/45 mm Hg, and an electrocardiogram free of
ST-segment, T-wave changes for at least 2 weeks with no
more than one premature ventricular contraction every 5
minutes.11
Immediate preoperative preparation should focus on
maximal abdominal decompression and visualization. A
nasogastric tube and Foley catheter are placed. The pa-
tient ideally should be positioned in the left lateral decu-
bitus position. This position can increase maternal cardiac
output by up to 20% and maximize blood flow to the
uterus and placenta.13 The first trocar should be placed in
the left upper quadrant or subxiphoid area under direct
visualization. After insufflation and inspection of the ab-
dominal cavity, subsequent trocars may be placed. Pneu-
moperitoneum should be maintained at a decreased pres-
sure of 10 mm Hg to 12 mm Hg. Continuous monitoring
for acidosis is also recommended.
The first successful report of laparoscopic adrenalectomy
for pheochromocytoma in pregnancy was published in
1999.14 Laparoscopic techniques for this type of tumor are
known to be technically demanding, becaause these tu-
mors are well vascularized.15 Although laparoscopic re-
section has become the preferred method of removal,
reports of robotic adrenalectomy have emerged. In a pro-
spective study of 109 patients, robotic adrenalectomy re-
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After an initial learning curve, operative times were com-
parable between the 2 groups. With comparable results,
robotic resection proved to be an available method of
removal. Robotic surgery has been proven feasible in
gynecologic oncology proving better initial outcomes in
complex operations than with laparoscopy.5
We present the first report of robotic resection of pheo-
chromocytoma in pregnancy. The robot offers advantages
including a 3-dimensional view, accurate and precise dis-
section, and enhanced freedom of motion within reduced
space.3,4,16 Visualization is steady and allows depth per-
ception that is lacking in traditional laparoscopy. Addi-
tionally, this technology provides adaptive downscaling of
the surgeon’s movement, eliminating tremor. Intraab-
dominal articulation provides safer and more efficient
dissection. The degrees of freedom of each instrument
permit virtually every angle desired for retraction, dissec-
tion, and resection. Optimal visualization and manipula-
tion coupled with a more ergonomic operation provide a
safe and comfortable option for this difficult case. These
benefits outweigh any disadvantages of using the robot.
Cost is always of concern as the initial price of the robotic
system is high. With every subsequent use, the cost of the
individual procedure decreases. The system is not ame-
nable to use for every surgical procedure due to its size
and time-consuming setup. Rare cases such as this one
justify these disadvantages.
This case also demonstrates the potential to push the
current recommendations for surgery during pregnancy.
Current guidelines state the second trimester is ideal.
Once the third trimester is reached, the uterus is too large
to permit adequate visualization and room for dissection.
These recommendations are for laparoscopic procedures.
The robot provides superior 3-dimensional visualization
and articulating instruments for dissection. This allows
performing the operation within a smaller space under
decreased pneumoperitoneum. This offers a unique ad-
vantage in this population. Using minimal insufflation
decreases intraabdominal pressure maximizing blood
flow to the uterus. Additionally, these advantages pro-
vided by the robot may enable later interventions. Third
trimester procedures may be possible using the robot.
CONCLUSION
Robotic resection of pheochromocytoma during preg-
nancy has not previously been reported. This case has
proved that the da Vinci Robotic System is a feasible and
safe procedure in the pregnant patient, providing unique
advantages in this difficult operation. It is important to
individualize surgical timing based in the features previ-
ously described. Based on this, pregnant patients within
the second trimester are the best candidates due to the
low risk for maternal-fetal death during this period com-
pared with the first or third trimester.
Finally, these cases should be treated by multidisciplinary
teams to achieve the best outcome and minimize the
probabilities of complications. The da Vinci robotic-as-
sisted laparoscopic procedure plays an invaluable role in
the achievement of this goal in the surgical field.
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